Core Laboratories Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the microscope...
Cheap oil does no favors to companies in the oil and gas industry -- as investors in Core Laboratories (NYSE: CLB) can attest. Since the start of this year, oil reservoir description and "production enhancement" company Core Labs has lost 24% of its stock market value -- a loss twice as large as the 12% decline in oil prices since January.
But there's good news, too: According to Swiss megabanker Credit Suisse (a continental neighbor to Dutch-based Core Labs), the sell-off in Core Laboratories stock is giving investors an opportunity to pick up shares on the cheap. Credit Suisse thinks now's the time to buy -- and here are three reasons why.
Source: Fool.com
Core Laboratories Inc. Aktie
Leichtes Sell-Übergewicht bei Core Laboratories Inc. mit 3 Sell- gegenüber 0 Buy-Einschätzungen.
Ein negatives, wenn auch nicht starkes, Potenzial für Core Laboratories Inc. mit einem Kursziel von 14 € im Vergleich zu 15.0 €.
